Copay Assistance Is Meant to Defray Patient Drug Costs. Some Insurers Keep It Instead

Copay assistance is meant to defray patient drug costs. Some insurers keep it instead

For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he needs that costs more than $7,700 a month. Each year, Amgen, which makes the…

Insurers Are Pocketing Copay Assistance Funds Meant to Curb Patient Drug Costs

While some states ban insurers from using copay accumulator programs, oversight has stalled at the federal level.

Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.

For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he needs that costs more than $7,700 a month. Each year, Amgen, which makes the drug, called Enbrel, sent the coupon card worth thousands of dollars, and that counted toward Gruber’s health insurance deductible and out-of-pocket maximum. Using the card, Gruber usually met that maximum by February, l…

Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead. - Health Care Today

For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he needs that costs more than $7,700 a month. Each year, Amgen, which makes the drug, called Enbrel, sent the coupon card worth thousands of dollars, and that counted toward Gruber’s health insurance deductible and out-of-pocket maximum. Using the card, Gruber usually met that maximum by February, l…